<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Ayu</journal-id><journal-id journal-id-type="iso-abbrev">Ayu</journal-id><journal-id journal-id-type="publisher-id">AYU</journal-id><journal-title-group><journal-title>Ayu</journal-title></journal-title-group><issn pub-type="ppub">0974-8520</issn><issn pub-type="epub">0976-9382</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26730141</article-id><article-id pub-id-type="pmc">4687242</article-id><article-id pub-id-type="publisher-id">AYU-36-63</article-id><article-id pub-id-type="doi">10.4103/0974-8520.169002</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group></article-categories><title-group><article-title>Efficacy of <italic>Ashwagandha</italic> (<italic>Withania somnifera</italic> [L.] Dunal) in improving cardiorespiratory endurance in healthy athletic adults</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Choudhary</surname><given-names>Bakhtiar</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Shetty</surname><given-names>A.</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Langade</surname><given-names>Deepak G.</given-names></name><xref ref-type="aff" rid="aff3">2</xref><xref ref-type="corresp" rid="cor1"></xref></contrib></contrib-group><aff id="aff1">Hyderabad Spine Clinic, Hyderabad, Andhra Pradesh, India</aff><aff id="aff2"><label>1</label>Zela Life Health Center, Bengaluru, Karnataka, India</aff><aff id="aff3"><label>2</label>Department of Pharmacology, BVDU Dental College and Hospital, Navi Mumbai, Maharashtra, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Deepak G. Langade, Dept. of Pharmacology, B.V.D.U. Dental College and Hospital, Sector 7, C.B.D. Belpada, Navi Mumbai - 400 614, Maharashtra, India. E-mail: <email xlink:href="drdgl@hotmail.com">drdgl@hotmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Mar</season><year>2015</year></pub-date><volume>36</volume><issue>1</issue><fpage>63</fpage><lpage>68</lpage><permissions><copyright-statement>Copyright: © AYU (An International Quarterly Journal of Research in Ayurveda)</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="3209" xml_f="3222" txt_i="11" txt_f="24">Introduction:</offsets></title><p><italic><offsets xml_i="3241" xml_f="3252" txt_i="25" txt_f="36">Ashwagandha</offsets></italic><offsets xml_i="3261" xml_f="3263" txt_i="36" txt_f="38"> (</offsets><italic><offsets xml_i="3271" xml_f="3289" txt_i="38" txt_f="56">Withania somnifera</offsets></italic><offsets xml_i="3298" xml_f="3628" txt_i="56" txt_f="386"> [L.] Dunal) has been traditionally used for various actions ranging from vitalizer, improve endurance and stamina, promote longevity, improve immunity, and male and female fertility. However, clinical studies are needed to prove the clinical efficacy of this herb, especially in cardiovascular endurance and physical performance.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3659" xml_f="3664" txt_i="388" txt_f="393">Aims:</offsets></title><p><offsets xml_i="3675" xml_f="3774" txt_i="394" txt_f="493">This prospective, double-blind, randomized, and placebo-controlled study evaluated the efficacy of </offsets><italic><offsets xml_i="3782" xml_f="3793" txt_i="493" txt_f="504">Ashwagandha</offsets></italic><offsets xml_i="3802" xml_f="3940" txt_i="504" txt_f="642"> roots extract in enhancing cardiorespiratory endurance and improving the quality of life (QOL) in 50 healthy male/female athletic adults.</offsets></p></sec><sec id="st3"><title><offsets xml_i="3971" xml_f="3993" txt_i="644" txt_f="666">Materials and Methods:</offsets></title><p><offsets xml_i="4004" xml_f="4110" txt_i="667" txt_f="773">Cardiorespiratory endurance was assessed by measuring the oxygen consumption at peak physical exertion (VO</offsets><sub><offsets xml_i="4115" xml_f="4116" txt_i="773" txt_f="774">2</offsets></sub><offsets xml_i="4122" xml_f="4356" txt_i="774" txt_f="1008"> max) levels during a 20 m shuttle run test. The World Health Organization self-reported QOL questionnaire (physical health, psychological health, social relationships, and environmental factors) was used to assess the QOL. Student's </offsets><italic><offsets xml_i="4364" xml_f="4365" txt_i="1008" txt_f="1009">t</offsets></italic><offsets xml_i="4374" xml_f="4453" txt_i="1009" txt_f="1088">-test was used to compare the differences in a mean and change from baseline VO</offsets><sub><offsets xml_i="4458" xml_f="4459" txt_i="1088" txt_f="1089">2</offsets></sub><offsets xml_i="4465" xml_f="4585" txt_i="1089" txt_f="1209"> max levels, whereas Wilcoxon signed-rank test was used to assess changes in QOL scores from baseline in the two groups.</offsets></p></sec><sec id="st4"><title><offsets xml_i="4616" xml_f="4624" txt_i="1211" txt_f="1219">Results:</offsets></title><p><offsets xml_i="4635" xml_f="4679" txt_i="1220" txt_f="1264">There was a greater increase from baseline (</offsets><italic><offsets xml_i="4687" xml_f="4688" txt_i="1264" txt_f="1265">P</offsets></italic><offsets xml_i="4697" xml_f="4725" txt_i="1265" txt_f="1290"> &lt; 0.0001) in the mean VO</offsets><sub><offsets xml_i="4730" xml_f="4731" txt_i="1290" txt_f="1291">2</offsets></sub><offsets xml_i="4737" xml_f="4754" txt_i="1291" txt_f="1308"> max with KSM-66 </offsets><italic><offsets xml_i="4762" xml_f="4773" txt_i="1308" txt_f="1319">Ashwagandha</offsets></italic><offsets xml_i="4782" xml_f="4784" txt_i="1319" txt_f="1321"> (</offsets><italic><offsets xml_i="4792" xml_f="4793" txt_i="1321" txt_f="1322">n</offsets></italic><offsets xml_i="4802" xml_f="4830" txt_i="1322" txt_f="1350"> = 24) compared to placebo (</offsets><italic><offsets xml_i="4838" xml_f="4839" txt_i="1350" txt_f="1351">n</offsets></italic><offsets xml_i="4848" xml_f="5026" txt_i="1351" txt_f="1529"> = 25) at 8 weeks (4.91 and 1.42, respectively) and at 12 weeks (5.67 and 1.86 respectively). The QOL scores for all subdomains significantly improved to a greater extent in the </offsets><italic><offsets xml_i="5034" xml_f="5045" txt_i="1529" txt_f="1540">Ashwagandha</offsets></italic><offsets xml_i="5054" xml_f="5094" txt_i="1540" txt_f="1580"> group at 12 weeks compared to placebo (</offsets><italic><offsets xml_i="5102" xml_f="5103" txt_i="1580" txt_f="1581">P</offsets></italic><offsets xml_i="5112" xml_f="5124" txt_i="1581" txt_f="1590"> &lt; 0.05).</offsets></p></sec><sec id="st5"><title><offsets xml_i="5155" xml_f="5166" txt_i="1592" txt_f="1603">Conclusion:</offsets></title><p><offsets xml_i="5177" xml_f="5203" txt_i="1604" txt_f="1630">The findings suggest that </offsets><italic><offsets xml_i="5211" xml_f="5222" txt_i="1630" txt_f="1641">Ashwagandha</offsets></italic><offsets xml_i="5231" xml_f="5330" txt_i="1641" txt_f="1740"> root extract enhances the cardiorespiratory endurance and improves QOL in healthy athletic adults.</offsets></p></sec></abstract><kwd-group><kwd><italic>Ashwagandha</italic></kwd><kwd>cardiorespiratory endurance</kwd><kwd>healthy athletics adults</kwd><kwd>quality of life</kwd><kwd>VO<sub>2</sub> max</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title><offsets xml_i="5611" xml_f="5623" txt_i="1749" txt_f="1761">Introduction</offsets></title><p><italic><offsets xml_i="5642" xml_f="5653" txt_i="1762" txt_f="1773">Ashwagandha</offsets></italic><offsets xml_i="5662" xml_f="5664" txt_i="1773" txt_f="1775"> (</offsets><italic><offsets xml_i="5672" xml_f="5690" txt_i="1775" txt_f="1793">Withania somnifera</offsets></italic><offsets xml_i="5699" xml_f="6034" txt_i="1793" txt_f="2128"> [L.] Dunal), also known as Indian Winter Cherry, is extensively used in Ayurveda, the traditional health care system in India. This herb is used as a general tonic and “adaptogen,” helping the body to adapt to stress. Also, it has been shown to possess antioxidant properties as well as an ability to support a healthy immune system.[</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="6067" xml_f="6068" txt_i="2128" txt_f="2129">1</offsets></xref><xref rid="ref2" ref-type="bibr"><offsets xml_i="6108" xml_f="6109" txt_i="2129" txt_f="2130">2</offsets></xref><xref rid="ref3" ref-type="bibr"><offsets xml_i="6149" xml_f="6150" txt_i="2130" txt_f="2131">3</offsets></xref><offsets xml_i="6157" xml_f="6158" txt_i="2131" txt_f="2132">]</offsets></p><p><italic><offsets xml_i="6173" xml_f="6184" txt_i="2133" txt_f="2144">Ashwagandha</offsets></italic><offsets xml_i="6193" xml_f="6388" txt_i="2144" txt_f="2339"> is a popular medicinal plant in the South East Asia and Southern Europe. Many people use this herb for general vitality. It is popularly called “Indian Ginseng” due to its rejuvenating effects.[</offsets><xref rid="ref2" ref-type="bibr"><offsets xml_i="6421" xml_f="6422" txt_i="2339" txt_f="2340">2</offsets></xref><xref rid="ref4" ref-type="bibr"><offsets xml_i="6462" xml_f="6463" txt_i="2340" txt_f="2341">4</offsets></xref><offsets xml_i="6470" xml_f="6621" txt_i="2341" txt_f="2492">] In addition, it causes relaxation, increases energy and promotes weight loss through stress reduction. In Ayurveda, certain herbal formulae known as </offsets><italic><offsets xml_i="6629" xml_f="6637" txt_i="2492" txt_f="2500">Rasayana</offsets></italic><offsets xml_i="6646" xml_f="6682" txt_i="2500" txt_f="2536"> are considered to be rejuvenating.[</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="6715" xml_f="6716" txt_i="2536" txt_f="2537">1</offsets></xref><xref rid="ref2" ref-type="bibr"><offsets xml_i="6756" xml_f="6757" txt_i="2537" txt_f="2538">2</offsets></xref><xref rid="ref5" ref-type="bibr"><offsets xml_i="6797" xml_f="6798" txt_i="2538" txt_f="2539">5</offsets></xref><xref rid="ref6" ref-type="bibr"><offsets xml_i="6838" xml_f="6839" txt_i="2539" txt_f="2540">6</offsets></xref><xref rid="ref7" ref-type="bibr"><offsets xml_i="6879" xml_f="6880" txt_i="2540" txt_f="2541">7</offsets></xref><xref rid="ref8" ref-type="bibr"><offsets xml_i="6920" xml_f="6921" txt_i="2541" txt_f="2542">8</offsets></xref><xref rid="ref9" ref-type="bibr"><offsets xml_i="6961" xml_f="6962" txt_i="2542" txt_f="2543">9</offsets></xref><offsets xml_i="6969" xml_f="7043" txt_i="2543" txt_f="2617">] and are taken as a remedy for general weakness, exhaustion, and stress. </offsets><italic><offsets xml_i="7051" xml_f="7062" txt_i="2617" txt_f="2628">Ashwagandha</offsets></italic><offsets xml_i="7071" xml_f="7268" txt_i="2628" txt_f="2825"> is valued for its ability to increase vitality, energy, endurance and stamina, promote longevity and strengthen the immune system without stimulating the body's reserves. Numerous studies suggest </offsets><italic><offsets xml_i="7276" xml_f="7287" txt_i="2825" txt_f="2836">Ashwagandha</offsets></italic><offsets xml_i="7296" xml_f="7365" txt_i="2836" txt_f="2905"> can directly and indirectly prevent and treat a number of diseases.[</offsets><xref rid="ref8" ref-type="bibr"><offsets xml_i="7398" xml_f="7399" txt_i="2905" txt_f="2906">8</offsets></xref><xref rid="ref10" ref-type="bibr"><offsets xml_i="7440" xml_f="7442" txt_i="2906" txt_f="2908">10</offsets></xref><xref rid="ref11" ref-type="bibr"><offsets xml_i="7483" xml_f="7485" txt_i="2908" txt_f="2910">11</offsets></xref><offsets xml_i="7492" xml_f="7493" txt_i="2910" txt_f="2911">]</offsets></p><p><offsets xml_i="7500" xml_f="7562" txt_i="2912" txt_f="2974">Earlier studies clearly indicated that the traditional use of </offsets><italic><offsets xml_i="7570" xml_f="7581" txt_i="2974" txt_f="2985">Ashwagandha</offsets></italic><offsets xml_i="7590" xml_f="7627" txt_i="2985" txt_f="3022"> had a logical and scientific basis.[</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="7660" xml_f="7661" txt_i="3022" txt_f="3023">1</offsets></xref><xref rid="ref2" ref-type="bibr"><offsets xml_i="7701" xml_f="7702" txt_i="3023" txt_f="3024">2</offsets></xref><offsets xml_i="7709" xml_f="7986" txt_i="3024" txt_f="3301">] Nonetheless; clinical studies are needed to prove the clinical efficacy of this herb, especially in cardiovascular endurance and physical performance. Hence, this study was conducted with a two-fold objective: To evaluate the efficacy of a high concentration root extract of </offsets><italic><offsets xml_i="7994" xml_f="8005" txt_i="3301" txt_f="3312">Ashwagandha</offsets></italic><offsets xml_i="8014" xml_f="8125" txt_i="3312" txt_f="3423"> in enhancing cardiorespiratory endurance, and to improve the quality of life (QOL) in healthy athletic adults.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="8188" xml_f="8209" txt_i="3425" txt_f="3446">Materials and Methods</offsets></title><p><offsets xml_i="8220" xml_f="8602" txt_i="3447" txt_f="3829">This randomized, double-blind, and placebo-controlled study was approved by Suraksha Independent Ethics Committee, Vishnu Institute of Pharmaceutical Education and Research, Andhra Pradesh, India (ref. no. SIEC/04/01/0014; dt. 13.04.2012) and the study was conducted in compliance with good clinical practice guidelines, Declaration of Helsinki and all other applicable regulations.</offsets></p><sec id="sec2-1"><title><offsets xml_i="8630" xml_f="8644" txt_i="3830" txt_f="3844">Study subjects</offsets></title><p><offsets xml_i="8655" xml_f="9070" txt_i="3845" txt_f="4260">A total of 50 subjects were assessed with regards to eligibility for inclusion in the study at the Department of Orthopedics, Hyderabad Spine Clinics, Secunderabad, India. This being an exploratory study, the sample size was not based on any assumptions and calculations. Healthy athletic male and/or female adult subjects aged between 20 and 45 years and subjects within the body mass index range of 18.5–24.9 kg/m</offsets><sup><offsets xml_i="9075" xml_f="9076" txt_i="4260" txt_f="4261">2</offsets></sup><offsets xml_i="9082" xml_f="9698" txt_i="4261" txt_f="4874"> were enrolled in the study after obtaining informed written consent. Subjects with previous history of significant renal or hepatic impairment, asthma, urticarial, or other allergic reactions, severe gastrointestinal disorders such as malabsorption syndrome, diabetes, coronary artery disease, and hypertension with or without complications, any chronic physical, hormonal or psychiatric disorder, morbid obesity (body fat percent &gt;40%), and any medical condition where exercise is contraindicated and recent surgery or trauma that incapacitates the subject for exercise, subjects with known hypersensitivity to </offsets><italic><offsets xml_i="9706" xml_f="9717" txt_i="4874" txt_f="4885">Ashwagandha</offsets></italic><offsets xml_i="9726" xml_f="9866" txt_i="4885" txt_f="5025"> and related herbal product extracts, and those subjects who were on any kind of herbal preparations (such as other formulations containing </offsets><italic><offsets xml_i="9874" xml_f="9885" txt_i="5025" txt_f="5036">Ashwagandha</offsets></italic><offsets xml_i="9894" xml_f="9905" txt_i="5036" txt_f="5047">, Ginseng, </offsets><italic><offsets xml_i="9913" xml_f="9919" txt_i="5047" txt_f="5053">Brahmi</offsets></italic><offsets xml_i="9928" xml_f="9968" txt_i="5053" txt_f="5093">, and Ginkgo biloba) were also excluded.</offsets></p></sec><sec id="sec2-2"><title><offsets xml_i="10002" xml_f="10015" txt_i="5095" txt_f="5108">Randomization</offsets></title><p><offsets xml_i="10026" xml_f="10099" txt_i="5109" txt_f="5182">The enrolled subjects were randomized to either placebo (control) group (</offsets><italic><offsets xml_i="10107" xml_f="10108" txt_i="5182" txt_f="5183">n</offsets></italic><offsets xml_i="10117" xml_f="10128" txt_i="5183" txt_f="5194"> = 25), or </offsets><italic><offsets xml_i="10136" xml_f="10147" txt_i="5194" txt_f="5205">Ashwagandha</offsets></italic><offsets xml_i="10156" xml_f="10172" txt_i="5205" txt_f="5221"> (study) group (</offsets><italic><offsets xml_i="10180" xml_f="10181" txt_i="5221" txt_f="5222">n</offsets></italic><offsets xml_i="10190" xml_f="10681" txt_i="5222" txt_f="5713"> = 25). Randomization was done using a computer based predetermined randomization chart (Rando 1.2, R. Raveendran, 2014). After the subjects were enrolled, they were provided a study serial number in chronological order. The study and placebo capsules were provide in containers without revealing the contents of the capsule and were numbered as per the randomization chart. Only after the subjects were assigned the study serial number, the corresponding container was given to the subject.</offsets></p><p><offsets xml_i="10688" xml_f="10714" txt_i="5714" txt_f="5740">The study subjects in the </offsets><italic><offsets xml_i="10722" xml_f="10733" txt_i="5740" txt_f="5751">Ashwagandha</offsets></italic><offsets xml_i="10742" xml_f="10789" txt_i="5751" txt_f="5798"> group were administered one capsule of KSM-66 </offsets><italic><offsets xml_i="10797" xml_f="10808" txt_i="5798" txt_f="5809">Ashwagandha</offsets></italic><offsets xml_i="10817" xml_f="10895" txt_i="5809" txt_f="5887"> (containing 300 mg of a high concentration full-spectrum root extract of the </offsets><italic><offsets xml_i="10903" xml_f="10914" txt_i="5887" txt_f="5898">Ashwagandha</offsets></italic><offsets xml_i="10923" xml_f="11093" txt_i="5898" txt_f="6068"> plant, Ixoreal Bio-med Private Ltd.,) orally, twice daily for a period of 12 weeks, whereas the subjects in placebo group received identical capsules containing sucrose.</offsets></p><p><offsets xml_i="11100" xml_f="11104" txt_i="6069" txt_f="6073">The </offsets><italic><offsets xml_i="11112" xml_f="11123" txt_i="6073" txt_f="6084">Ashwagandha</offsets></italic><offsets xml_i="11132" xml_f="11732" txt_i="6084" txt_f="6684"> root extract (KSM-66 Ashwagandha from Ixoreal Biomed, Hyderabad, India) used in this study has been standardized to 5% withanolides as ascertained by high-performance liquid chromatography (HPLC). It is manufactured using a proprietary water-based process, without the use of alcohol or any chemical solvents. The analysis of withanolides was performed with a Waters 515 HPLC System, using a Sunfire C18 column of dimension 250 mm × 4.6 mm, 5 µm at a flow rate of 1 ml/min. The solvent system was based on methanol: water (60:40). The column temperature was 30°C, and the injection volume was 20 µl.</offsets></p></sec><sec id="sec2-3"><title><offsets xml_i="11766" xml_f="11794" txt_i="6686" txt_f="6714">Study visits and assessments</offsets></title><p><offsets xml_i="11805" xml_f="12009" txt_i="6715" txt_f="6919">During the study period, the subjects visited the study center at screening and enrollment and then after 4, 8, and 12 weeks. All enrolled subjects underwent a complete physical examination at all visits.</offsets></p><p><offsets xml_i="12016" xml_f="12032" txt_i="6920" txt_f="6936">The efficacy of </offsets><italic><offsets xml_i="12040" xml_f="12051" txt_i="6936" txt_f="6947">Ashwagandha</offsets></italic><offsets xml_i="12060" xml_f="12225" txt_i="6947" txt_f="7112"> on cardiorespiratory endurance was evaluated by conducting a 20-m Shuttle Run Test at baseline, week 8 and week 12. Oxygen consumption at peak physical exertion (VO</offsets><sub><offsets xml_i="12230" xml_f="12231" txt_i="7112" txt_f="7113">2</offsets></sub><offsets xml_i="12237" xml_f="12336" txt_i="7113" txt_f="7212"> max) is one of the most widely used indicator of cardiorespiratory endurance and shuttle run test[</offsets><xref rid="ref12" ref-type="bibr"><offsets xml_i="12370" xml_f="12372" txt_i="7212" txt_f="7214">12</offsets></xref><offsets xml_i="12379" xml_f="12430" txt_i="7214" txt_f="7265">] is found to be a reliable substitute to assess VO</offsets><sub><offsets xml_i="12435" xml_f="12436" txt_i="7265" txt_f="7266">2</offsets></sub><offsets xml_i="12442" xml_f="12487" txt_i="7266" txt_f="7311"> max, when laboratory-based assessments of VO</offsets><sub><offsets xml_i="12492" xml_f="12493" txt_i="7311" txt_f="7312">2</offsets></sub><offsets xml_i="12499" xml_f="12522" txt_i="7312" txt_f="7335"> max are not feasible.[</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="12556" xml_f="12558" txt_i="7335" txt_f="7337">13</offsets></xref><offsets xml_i="12565" xml_f="12566" txt_i="7337" txt_f="7338">]</offsets></p><p><offsets xml_i="12573" xml_f="13005" txt_i="7339" txt_f="7771">The QOL was assessed by a self-reported World Health Organization-QOL (WHO-QOL) questionnaire. This QOL had subdomains for assessment of physical health, psychological health, social relationships, and environmental factors. Compliance was assessed using the capsule count and those who consumed over 80% of tablets were classified as compliant. All data were recorded in the source documents and data collection forms for 12 weeks.</offsets></p></sec><sec id="sec2-4"><title><offsets xml_i="13039" xml_f="13059" txt_i="7773" txt_f="7793">Statistical analysis</offsets></title><p><offsets xml_i="13070" xml_f="13140" txt_i="7794" txt_f="7864">The data were analyzed using windows based statistical program Medcalc</offsets><sup><offsets xml_i="13145" xml_f="13146" txt_i="7864" txt_f="7865">®</offsets></sup><offsets xml_i="13152" xml_f="13179" txt_i="7865" txt_f="7892"> (Version 12.7.0.0). The VO</offsets><sub><offsets xml_i="13184" xml_f="13185" txt_i="7892" txt_f="7893">2</offsets></sub><offsets xml_i="13191" xml_f="13291" txt_i="7893" txt_f="7993"> max and QOL scores are expressed as a means with SD. Mann–Whitney U-test was used to compare the VO</offsets><sub><offsets xml_i="13296" xml_f="13297" txt_i="7993" txt_f="7994">2</offsets></sub><offsets xml_i="13303" xml_f="13557" txt_i="7994" txt_f="8248"> max values with 20-m Shuttle Run Test between the two groups. Similarly, Wilcoxon signed-rank test was used to compare the two groups for differences in the QOL scores and change from baseline in QOL scores for different subdomains of QOL questionnaire.</offsets></p></sec></sec><sec sec-type="results" id="sec1-3"><title><offsets xml_i="13616" xml_f="13623" txt_i="8251" txt_f="8258">Results</offsets></title><p><offsets xml_i="13634" xml_f="13655" txt_i="8259" txt_f="8280">One subject from the </offsets><italic><offsets xml_i="13663" xml_f="13674" txt_i="8280" txt_f="8291">Ashwagandha</offsets></italic><offsets xml_i="13683" xml_f="13807" txt_i="8291" txt_f="8415"> group withdrew consent from the study and was not included for analysis. Thus, data of 49 subjects were used for analysis [</offsets><xref ref-type="fig" rid="F1"><offsets xml_i="13837" xml_f="13849" txt_i="8415" txt_f="8427">Flow chart 1</offsets></xref><offsets xml_i="13856" xml_f="13999" txt_i="8427" txt_f="8570">]. The subjects from the two groups were comparable and had a matching demographic profile. The compliance was satisfactory in both the groups.</offsets></p><fig id="F1" position="float"><label><offsets xml_i="14040" xml_f="14052" txt_i="8571" txt_f="8583">Flow Chart 1</offsets></label><caption><p><offsets xml_i="14072" xml_f="14097" txt_i="8583" txt_f="8608">Consort 2010 flow diagram</offsets></p></caption><graphic xlink:href="AYU-36-63-g001"></graphic></fig><p><offsets xml_i="14167" xml_f="14202" txt_i="8609" txt_f="8644">Treatment with the root extract of </offsets><italic><offsets xml_i="14210" xml_f="14221" txt_i="8644" txt_f="8655">Ashwagandha</offsets></italic><offsets xml_i="14230" xml_f="14277" txt_i="8655" txt_f="8702"> resulted in a significantly greater increase (</offsets><italic><offsets xml_i="14285" xml_f="14286" txt_i="8702" txt_f="8703">P</offsets></italic><offsets xml_i="14295" xml_f="14319" txt_i="8703" txt_f="8724"> &lt; 0.0001) in mean VO</offsets><sub><offsets xml_i="14324" xml_f="14325" txt_i="8724" txt_f="8725">2</offsets></sub><offsets xml_i="14331" xml_f="14388" txt_i="8725" txt_f="8782"> max at week 8 and week 12 compared to placebo subjects [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="14420" xml_f="14427" txt_i="8782" txt_f="8789">Table 1</offsets></xref><offsets xml_i="14434" xml_f="14480" txt_i="8789" txt_f="8835">]. The QOL sub-domain scores are presented in </offsets><xref ref-type="table" rid="T2"><offsets xml_i="14512" xml_f="14519" txt_i="8835" txt_f="8842">Table 2</offsets></xref><offsets xml_i="14526" xml_f="14528" txt_i="8842" txt_f="8844">. </offsets><italic><offsets xml_i="14536" xml_f="14547" txt_i="8844" txt_f="8855">Ashwagandha</offsets></italic><offsets xml_i="14556" xml_f="14654" txt_i="8855" txt_f="8953"> has shown to exert a greater improvement in all the QOL sub-domain scores as compared to placebo.</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="14702" xml_f="14709" txt_i="8954" txt_f="8961">Table 1</offsets></label><caption><p><offsets xml_i="14729" xml_f="14774" txt_i="8961" txt_f="9006">Assessment of VO2max by 20-m shuttle run test</offsets></p></caption><graphic xlink:href="AYU-36-63-g002"></graphic></table-wrap><table-wrap id="T2" position="float"><label><offsets xml_i="14892" xml_f="14899" txt_i="9007" txt_f="9014">Table 2</offsets></label><caption><p><offsets xml_i="14919" xml_f="14955" txt_i="9014" txt_f="9050">Assessments of WHO-QOL questionnaire</offsets></p></caption><graphic xlink:href="AYU-36-63-g003"></graphic></table-wrap><p><offsets xml_i="15032" xml_f="15077" txt_i="9051" txt_f="9096">The data of this study showed a significant (</offsets><italic><offsets xml_i="15085" xml_f="15086" txt_i="9096" txt_f="9097">P</offsets></italic><offsets xml_i="15095" xml_f="15430" txt_i="9097" txt_f="9429"> &lt; 0.05) improvement in the physical and psychological health and the social relationship status of the study subjects by the end of 12 weeks of the study. However, the status of the environmental impact on the QOL of the study subjects was found to have increased substantially; albeit, not significant at 8 weeks and significant (</offsets><italic><offsets xml_i="15438" xml_f="15439" txt_i="9429" txt_f="9430">P</offsets></italic><offsets xml_i="15448" xml_f="15664" txt_i="9430" txt_f="9643"> &lt; 0.01) at 12 weeks of the study period. There were no changes in the vital parameters such as pulse rate, blood pressure (systolic and diastolic), and respiratory at resting state in the subjects of both groups.</offsets></p></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="15720" xml_f="15730" txt_i="9645" txt_f="9655">Discussion</offsets></title><p><offsets xml_i="15741" xml_f="15799" txt_i="9656" txt_f="9714">This study aimed to assess the effects of root extract of </offsets><italic><offsets xml_i="15807" xml_f="15818" txt_i="9714" txt_f="9725">Ashwagandha</offsets></italic><offsets xml_i="15827" xml_f="16381" txt_i="9725" txt_f="10279"> on cardiorespiratory endurance in healthy athletic adults and to evaluate the QOL of these subjects. Isometric exercise involves daily and athletic activity, which significantly increases blood pressure, heart rate, myocardial contractility, and cardiac output; this enhanced physiological activity requires a fit cardiorespiratory system. A study in children and adolescents suggests that low cardiorespiratory fitness is strongly associated with the clustering of cardiovascular disease risk factors in children, independent of country, age, and sex.[</offsets><xref rid="ref14" ref-type="bibr"><offsets xml_i="16415" xml_f="16417" txt_i="10279" txt_f="10281">14</offsets></xref><xref rid="ref15" ref-type="bibr"><offsets xml_i="16458" xml_f="16460" txt_i="10281" txt_f="10283">15</offsets></xref><offsets xml_i="16467" xml_f="16597" txt_i="10283" txt_f="10413">] Cardiorespiratory endurance is generally recognized as a major component of physical fitness. The maximum oxygen consumption (VO</offsets><sub><offsets xml_i="16602" xml_f="16603" txt_i="10413" txt_f="10414">2</offsets></sub><offsets xml_i="16609" xml_f="16693" txt_i="10414" txt_f="10498"> max) is considered by many as the most valid measure of cardiorespiratory fitness.[</offsets><xref rid="ref16" ref-type="bibr"><offsets xml_i="16727" xml_f="16729" txt_i="10498" txt_f="10500">16</offsets></xref><xref rid="ref17" ref-type="bibr"><offsets xml_i="16770" xml_f="16772" txt_i="10500" txt_f="10502">17</offsets></xref><offsets xml_i="16779" xml_f="16780" txt_i="10502" txt_f="10503">]</offsets></p><p><offsets xml_i="16787" xml_f="16802" txt_i="10504" txt_f="10519">The test for VO</offsets><sub><offsets xml_i="16807" xml_f="16808" txt_i="10519" txt_f="10520">2</offsets></sub><offsets xml_i="16814" xml_f="17094" txt_i="10520" txt_f="10800"> max is perhaps the most commonly employed procedure in exercise physiology. This measurement determines an athlete's ability to take in, transport, and utilize oxygen and is probably the best assessments of the athlete's endurance capabilities. The maximum oxygen consumption (VO</offsets><sub><offsets xml_i="17099" xml_f="17100" txt_i="10800" txt_f="10801">2</offsets></sub><offsets xml_i="17106" xml_f="17189" txt_i="10801" txt_f="10884"> max) is a measure of long-term aerobic and cardiovascular endurance parameters. VO</offsets><sub><offsets xml_i="17194" xml_f="17195" txt_i="10884" txt_f="10885">2</offsets></sub><offsets xml_i="17201" xml_f="17357" txt_i="10885" txt_f="11041"> max represents a long-term aerobic and cardiovascular endurance and is considered to be a gold standard for measuring the cardiorespiratory fitness level.[</offsets><xref rid="ref16" ref-type="bibr"><offsets xml_i="17391" xml_f="17393" txt_i="11041" txt_f="11043">16</offsets></xref><xref rid="ref18" ref-type="bibr"><offsets xml_i="17434" xml_f="17436" txt_i="11043" txt_f="11045">18</offsets></xref><offsets xml_i="17443" xml_f="17530" txt_i="11045" txt_f="11132">] Endurance activities characteristically require high repetitions and low resistance.[</offsets><xref rid="ref16" ref-type="bibr"><offsets xml_i="17564" xml_f="17566" txt_i="11132" txt_f="11134">16</offsets></xref><offsets xml_i="17573" xml_f="17663" txt_i="11134" txt_f="11224">] A study states that 20 m shuttle run test is valid and reliable for prediction of the VO</offsets><sub><offsets xml_i="17668" xml_f="17669" txt_i="11224" txt_f="11225">2</offsets></sub><offsets xml_i="17675" xml_f="17707" txt_i="11225" txt_f="11257"> max of male and female adults.[</offsets><xref rid="ref19" ref-type="bibr"><offsets xml_i="17741" xml_f="17743" txt_i="11257" txt_f="11259">19</offsets></xref><offsets xml_i="17750" xml_f="17897" txt_i="11259" txt_f="11406">] The 20 m shuttle run test is as a valid test of cardiorespiratory endurance as other distance run tests in American Students of 12–15 years old.[</offsets><xref rid="ref20" ref-type="bibr"><offsets xml_i="17931" xml_f="17933" txt_i="11406" txt_f="11408">20</offsets></xref><offsets xml_i="17940" xml_f="18001" txt_i="11408" txt_f="11469">] In this study, 20 m shuttle run test was used to measure VO</offsets><sub><offsets xml_i="18006" xml_f="18007" txt_i="11469" txt_f="11470">2</offsets></sub><offsets xml_i="18013" xml_f="18140" txt_i="11470" txt_f="11597"> max levels which in turn depicted the cardiorespiratory endurance. It was observed that there was a significant increase in VO</offsets><sub><offsets xml_i="18145" xml_f="18146" txt_i="11597" txt_f="11598">2</offsets></sub><offsets xml_i="18152" xml_f="18298" txt_i="11598" txt_f="11744"> max by the end of 8 weeks and by the end of 12 weeks as compared to placebo group. The data of the present study defined an excellent range of VO</offsets><sub><offsets xml_i="18303" xml_f="18304" txt_i="11744" txt_f="11745">2</offsets></sub><offsets xml_i="18310" xml_f="18343" txt_i="11745" txt_f="11778"> max following administration of </offsets><italic><offsets xml_i="18351" xml_f="18362" txt_i="11778" txt_f="11789">Ashwagandha</offsets></italic><offsets xml_i="18371" xml_f="18372" txt_i="11789" txt_f="11790">.</offsets></p><p><italic><offsets xml_i="18387" xml_f="18398" txt_i="11791" txt_f="11802">Ashwagandha</offsets></italic><offsets xml_i="18407" xml_f="18548" txt_i="11802" txt_f="11943"> is known as an “adaptogen,” as it increases resistance to physical, chemical, and biological stressors, builds energy and general vitality.[</offsets><xref rid="ref2" ref-type="bibr"><offsets xml_i="18581" xml_f="18582" txt_i="11943" txt_f="11944">2</offsets></xref><xref rid="ref7" ref-type="bibr"><offsets xml_i="18622" xml_f="18623" txt_i="11944" txt_f="11945">7</offsets></xref><xref rid="ref18" ref-type="bibr"><offsets xml_i="18664" xml_f="18666" txt_i="11945" txt_f="11947">18</offsets></xref><xref rid="ref21" ref-type="bibr"><offsets xml_i="18707" xml_f="18709" txt_i="11947" txt_f="11949">21</offsets></xref><offsets xml_i="18716" xml_f="18874" txt_i="11949" txt_f="12107">] Previous studies assessing physical and cardiorespiratory endurance of healthy adult subjects have also reported similar beneficial results with the use of </offsets><italic><offsets xml_i="18882" xml_f="18893" txt_i="12107" txt_f="12118">Ashwagandha</offsets></italic><offsets xml_i="18902" xml_f="18947" txt_i="12118" txt_f="12163">, underscoring the significant increase in VO</offsets><sub><offsets xml_i="18952" xml_f="18953" txt_i="12163" txt_f="12164">2</offsets></sub><offsets xml_i="18959" xml_f="18990" txt_i="12164" txt_f="12195"> max and muscle strengthening.[</offsets><xref rid="ref18" ref-type="bibr"><offsets xml_i="19024" xml_f="19026" txt_i="12195" txt_f="12197">18</offsets></xref><xref rid="ref21" ref-type="bibr"><offsets xml_i="19067" xml_f="19069" txt_i="12197" txt_f="12199">21</offsets></xref><offsets xml_i="19076" xml_f="19078" txt_i="12199" txt_f="12201">] </offsets><italic><offsets xml_i="19086" xml_f="19098" txt_i="12201" txt_f="12213">W. somnifera</offsets></italic><offsets xml_i="19107" xml_f="19368" txt_i="12213" txt_f="12474"> administered in the form of aqueous extract in capsules with gradual escalating doses from 750 to 1250 mg/day was found to be safe and well tolerated. The study also demonstrated marked muscle strengthening, exercise tolerance, and lipid-lowering potential of </offsets><italic><offsets xml_i="19376" xml_f="19387" txt_i="12474" txt_f="12485">Ashwagandha</offsets></italic><offsets xml_i="19396" xml_f="19444" txt_i="12485" txt_f="12533">, along with improved quality of sleep and QOL.[</offsets><xref rid="ref21" ref-type="bibr"><offsets xml_i="19478" xml_f="19480" txt_i="12533" txt_f="12535">21</offsets></xref><offsets xml_i="19487" xml_f="19488" txt_i="12535" txt_f="12536">]</offsets></p><p><offsets xml_i="19495" xml_f="19600" txt_i="12537" txt_f="12642">Adenosine triphosphate is responsible for the maintenance of the energy processes at the cellular level. </offsets><italic><offsets xml_i="19608" xml_f="19619" txt_i="12642" txt_f="12653">Ashwagandha</offsets></italic><offsets xml_i="19628" xml_f="19749" txt_i="12653" txt_f="12774"> has been shown to exert significant effects on the energy levels and mitochondrial health. It beneficially influences Mg</offsets><sup><offsets xml_i="19754" xml_f="19756" txt_i="12774" txt_f="12776">2+</offsets></sup><offsets xml_i="19762" xml_f="19970" txt_i="12776" txt_f="12984"> dependent ATPase activity and reduces the succinate dehydrogenase enzyme activity in the mitochondria of granulation tissue of carrageen induced air pouch granuloma as demonstrated in an experimental study.[</offsets><xref rid="ref22" ref-type="bibr"><offsets xml_i="20004" xml_f="20006" txt_i="12984" txt_f="12986">22</offsets></xref><offsets xml_i="20013" xml_f="20193" txt_i="12986" txt_f="13166">] In agreement with the fact that exercise endurance capacity is largely determined by the functional mitochondrial content of muscle, this study confirms the energizing effect of </offsets><italic><offsets xml_i="20201" xml_f="20212" txt_i="13166" txt_f="13177">Ashwagandha</offsets></italic><offsets xml_i="20221" xml_f="20246" txt_i="13177" txt_f="13202">. It has been shown that </offsets><italic><offsets xml_i="20254" xml_f="20265" txt_i="13202" txt_f="13213">Ashwagandha</offsets></italic><offsets xml_i="20274" xml_f="20519" txt_i="13213" txt_f="13458"> increased both the red blood corpuscles (RBC) and hemoglobin count. The increase in RBC results in an increased capacity of the blood to transport oxygen directly to the exercising muscles; thus, enhancing the aerobic capacity of the athletes.[</offsets><xref rid="ref23" ref-type="bibr"><offsets xml_i="20553" xml_f="20555" txt_i="13458" txt_f="13460">23</offsets></xref><xref rid="ref24" ref-type="bibr"><offsets xml_i="20596" xml_f="20598" txt_i="13460" txt_f="13462">24</offsets></xref><offsets xml_i="20605" xml_f="20678" txt_i="13462" txt_f="13535">] These findings suggest a possible mechanism of the ergogenic effect of </offsets><italic><offsets xml_i="20686" xml_f="20697" txt_i="13535" txt_f="13546">Ashwagandha</offsets></italic><offsets xml_i="20706" xml_f="20720" txt_i="13546" txt_f="13560"> root extract.</offsets></p><p><offsets xml_i="20727" xml_f="20790" txt_i="13561" txt_f="13624">An animal study reported a 2–3-fold increase in free radical (R</offsets><sup><offsets xml_i="20795" xml_f="20796" txt_i="13624" txt_f="13625">•</offsets></sup><offsets xml_i="20802" xml_f="20996" txt_i="13625" txt_f="13819">) concentrations of muscle and liver following exercise to exhaustion. Exhaustive exercise also resulted in decreased mitochondrial respiratory control and increased levels of oxidative stress.[</offsets><xref rid="ref25" ref-type="bibr"><offsets xml_i="21030" xml_f="21032" txt_i="13819" txt_f="13821">25</offsets></xref><offsets xml_i="21039" xml_f="21041" txt_i="13821" txt_f="13823">] </offsets><italic><offsets xml_i="21049" xml_f="21060" txt_i="13823" txt_f="13834">Ashwagandha</offsets></italic><offsets xml_i="21069" xml_f="21256" txt_i="13834" txt_f="14021"> on a long period of administration markedly augmented antioxidants and significantly reduced ischemia reperfusion induced myocardial injury as reported in an earlier experimental study.[</offsets><xref rid="ref26" ref-type="bibr"><offsets xml_i="21290" xml_f="21292" txt_i="14021" txt_f="14023">26</offsets></xref><xref rid="ref27" ref-type="bibr"><offsets xml_i="21333" xml_f="21335" txt_i="14023" txt_f="14025">27</offsets></xref><offsets xml_i="21342" xml_f="21413" txt_i="14025" txt_f="14096">] These observations are indicative of its cardio protective potential.</offsets></p><p><italic><offsets xml_i="21428" xml_f="21439" txt_i="14097" txt_f="14108">Ashwagandha</offsets></italic><offsets xml_i="21448" xml_f="21731" txt_i="14108" txt_f="14391"> as an herbal drug finds its mention in various reference books/literature on traditional medicines and is being used widely and since long. There are no reported Phase-I or Phase-II studies being conducted due to its known knowledge of safety and efficacy. In view of the fact that </offsets><italic><offsets xml_i="21739" xml_f="21750" txt_i="14391" txt_f="14402">Ashwagandha</offsets></italic><offsets xml_i="21759" xml_f="22141" txt_i="14402" txt_f="14784"> is an herb which is extensively used traditionally in Ayurveda, Phase-I and Phase-II trials may not be necessary. The herb under investigation is being clinically evaluated for the same indication for which it is being used or as has been described in ancient texts. Furthermore, the design of the trial is appropriate to provide the expected outcomes for the traditional medicine.</offsets></p><p><offsets xml_i="22148" xml_f="22396" txt_i="14785" txt_f="15033">The WHO-QOL questionnaire is used to evaluate a given subject's QOL. It comprises 26 items, which measures the following broad domains: Physical health, psychological health, social relationships, and the environment (WHO-QOL Questionnaire, 1996).[</offsets><xref rid="ref28" ref-type="bibr"><offsets xml_i="22430" xml_f="22432" txt_i="15033" txt_f="15035">28</offsets></xref><offsets xml_i="22439" xml_f="22613" txt_i="15035" txt_f="15209">] The procedure entails each question being read out to the subjects, along with the response options. In this study, QOL was checked by self-reported WHO-QOL Questionnaire. </offsets><italic><offsets xml_i="22621" xml_f="22632" txt_i="15209" txt_f="15220">Ashwagandha</offsets></italic><offsets xml_i="22641" xml_f="22891" txt_i="15220" txt_f="15470"> was shown to improve all subdomains of the QOL (physical health, psychological health, social relationships, and environmental factors) of the healthy athletic adult subjects as compared to placebo. The data of the present study showed significant (</offsets><italic><offsets xml_i="22899" xml_f="22900" txt_i="15470" txt_f="15471">P</offsets></italic><offsets xml_i="22909" xml_f="23287" txt_i="15471" txt_f="15846"> &lt; 0.05) improvement in physical and psychological health and these domains have a greater contribution in the QOL than the other domains of social relationships, and environmental factors. This study was first of its kind and limited by a small sample size. Further studies with a larger sample with an additional aims of understanding the underlying mechanism of action of </offsets><italic><offsets xml_i="23295" xml_f="23306" txt_i="15846" txt_f="15857">Ashwagandha</offsets></italic><offsets xml_i="23315" xml_f="23364" txt_i="15857" txt_f="15906"> may further validate the findings of this study.</offsets></p></sec><sec sec-type="conclusion" id="sec1-5"><title><offsets xml_i="23420" xml_f="23431" txt_i="15908" txt_f="15919">Conclusions</offsets></title><p><italic><offsets xml_i="23450" xml_f="23461" txt_i="15920" txt_f="15931">Ashwagandha</offsets></italic><offsets xml_i="23470" xml_f="23563" txt_i="15931" txt_f="16024"> an important herb in Ayurveda, the traditional Indian medicine system is considered to be a </offsets><italic><offsets xml_i="23571" xml_f="23579" txt_i="16024" txt_f="16032">Rasayana</offsets></italic><offsets xml_i="23588" xml_f="23590" txt_i="16032" txt_f="16034">. </offsets><italic><offsets xml_i="23598" xml_f="23609" txt_i="16034" txt_f="16045">Ashwagandha</offsets></italic><offsets xml_i="23618" xml_f="23954" txt_i="16045" txt_f="16381"> root extract has been used for several 1000 years in Ayurveda as a tonic, prophylactic agent and “restorative.” It has been used by athletes for improved muscular strength, resistance to fatigue, recovery from exercise, and as an ergogenic aid for many years. In this study, oral administration of a high concentration root extract of </offsets><italic><offsets xml_i="23962" xml_f="23973" txt_i="16381" txt_f="16392">Ashwagandha</offsets></italic><offsets xml_i="23982" xml_f="24002" txt_i="16392" txt_f="16412"> led to increased VO</offsets><sub><offsets xml_i="24007" xml_f="24008" txt_i="16412" txt_f="16413">2</offsets></sub><offsets xml_i="24014" xml_f="24139" txt_i="16413" txt_f="16538"> max, enhanced cardiorespiratory endurance, and improved QOL in healthy athletic adults. Findings of this study suggest that </offsets><italic><offsets xml_i="24147" xml_f="24158" txt_i="16538" txt_f="16549">Ashwagandha</offsets></italic><offsets xml_i="24167" xml_f="24238" txt_i="16549" txt_f="16620"> root extract improves the cardiovascular dynamics by increasing the VO</offsets><sub><offsets xml_i="24243" xml_f="24244" txt_i="16620" txt_f="16621">2</offsets></sub><offsets xml_i="24250" xml_f="24562" txt_i="16621" txt_f="16933"> max levels thereby enhancing the cardiorespiratory endurance, and also brings an improvement in QOL in healthy adults. However, due to the limited cross-section of the population considered in this study, the findings may not generalize to all populations. Further studies are needed to validate these findings.</offsets></p><sec id="sec2-5"><title><offsets xml_i="24590" xml_f="24623" txt_i="16934" txt_f="16967">Financial support and sponsorship</offsets></title><p><offsets xml_i="24634" xml_f="24638" txt_i="16968" txt_f="16972">Nil.</offsets></p></sec><sec id="sec2-6"><title><offsets xml_i="24672" xml_f="24693" txt_i="16974" txt_f="16995">Conflicts of interest</offsets></title><p><offsets xml_i="24704" xml_f="24739" txt_i="16996" txt_f="17031">There are no conflicts of interest.</offsets></p></sec></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Nath</surname><given-names>R</given-names></name><name><surname>Lata</surname><given-names>A</given-names></name><name><surname>Lata</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>SP</given-names></name><name><surname>Kohli</surname><given-names>RP</given-names></name><etal></etal></person-group><article-title><italic>Withania somnifera</italic> (<italic>Ashwagandha</italic>), a rejuvenating herbal drug which enhances survival during stress (an adaptogen)</article-title><source>Int J Crude Drug Res</source><year>1982</year><volume>20</volume><fpage>29</fpage><lpage>35</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>LC</given-names></name><name><surname>Singh</surname><given-names>BB</given-names></name><name><surname>Dagenais</surname><given-names>S</given-names></name></person-group><article-title>Scientific basis for the therapeutic use of <italic>Withania somnifera</italic> (<italic>Ashwagandha</italic>): a review</article-title><source>Altern Med Rev</source><year>2000</year><volume>5</volume><fpage>334</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">10956379</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Provino</surname><given-names>R</given-names></name></person-group><article-title>The role of adaptogens in stress management</article-title><source>Aust J Med Herbalism</source><year>2010</year><volume>22</volume><fpage>41</fpage><lpage>9</lpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Weiner</surname><given-names>MA</given-names></name><name><surname>Weiner</surname><given-names>J</given-names></name></person-group><article-title><italic>Ashwagandha</italic> (Indian ginseng)</article-title><source>Herbs that Heal</source><year>1994</year><publisher-loc>Mill Valley, CA</publisher-loc><publisher-name>Quantum Books</publisher-name><fpage>70</fpage><lpage>2</lpage></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Shastri</surname><given-names>B</given-names></name></person-group><source>Bhavprakash of Bhava Mishra, Guduchyadi Varg</source><year>1999</year><edition>9th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chowkhamba Sanskrit Sansthan</publisher-name><fpage>393</fpage><lpage>4</lpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>C</given-names></name><name><surname>Aswath</surname><given-names>A</given-names></name><name><surname>Chaturvedi</surname><given-names>SK</given-names></name><name><surname>Srinivasa</surname><given-names>M</given-names></name><name><surname>Raguram</surname><given-names>R</given-names></name></person-group><article-title>A double-blind, placebo-controlled evaluation of the anxiolytic efficacy of an ethanolic extract of <italic>Withania somnifera</italic></article-title><source>Indian J Psychiatry</source><year>2000</year><volume>42</volume><fpage>295</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">21407960</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhuley</surname><given-names>JN</given-names></name></person-group><article-title>Adaptogenic and cardioprotective action of <italic>Ashwagandha</italic> in rats and frogs</article-title><source>J Ethnopharmacol</source><year>2000</year><volume>70</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">10720789</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirjalili</surname><given-names>MH</given-names></name><name><surname>Moyano</surname><given-names>E</given-names></name><name><surname>Bonfill</surname><given-names>M</given-names></name><name><surname>Cusido</surname><given-names>RM</given-names></name><name><surname>Palazón</surname><given-names>J</given-names></name></person-group><article-title>Steroidal lactones from <italic>Withania somnifera</italic>, an ancient plant for novel medicine</article-title><source>Molecules</source><year>2009</year><volume>14</volume><fpage>2373</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">19633611</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Bhalla</surname><given-names>M</given-names></name><name><surname>de Jager</surname><given-names>P</given-names></name><name><surname>Gilca</surname><given-names>M</given-names></name></person-group><article-title>An overview on <italic>Ashwagandha</italic>: a <italic>Rasayana</italic> (rejuvenator) of Ayurveda</article-title><source>Afr J Tradit Complement Altern Med</source><year>2011</year><volume>8</volume><issue>5 Suppl</issue><fpage>208</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">22754076</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>CL</given-names></name><name><surname>Das</surname><given-names>PK</given-names></name><name><surname>Dhalla</surname><given-names>NS</given-names></name><name><surname>Prasad</surname><given-names>K</given-names></name></person-group><article-title>Studies on Withania <italic>Ashwagandha</italic>, Kaul. III. The effect of total alkaloids on the cardiovascular system and respiration</article-title><source>Indian J Med Res</source><year>1981</year><volume>49</volume><fpage>448</fpage><lpage>60</lpage></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sukanya</surname><given-names>DH</given-names></name><name><surname>Lokesha</surname><given-names>AN</given-names></name><name><surname>Datta</surname><given-names>G</given-names></name><name><surname>Himabindu</surname><given-names>K</given-names></name></person-group><article-title>Phytochemical diversity in <italic>Ashwagandha</italic> (<italic>Withania somnifera</italic>)</article-title><source>J Med Aromat Plants</source><year>2010</year><volume>1</volume><issue>2</issue><fpage>TS2</fpage><lpage>p26</lpage><comment>Abstract: National Conference on Biodiversity of Medicinal and Aromatic Plants: Collection, Characterization and Utilization, Held at Anand, India; 24-25 November, 2010</comment></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leger</surname><given-names>LA</given-names></name><name><surname>Lambert</surname><given-names>J</given-names></name></person-group><article-title>A maximal multistage 20m shuttle run test to predict VO2 max</article-title><source>Eur J Appl Physiol</source><year>1982</year><volume>49</volume><fpage>1</fpage><lpage>5</lpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cairney</surname><given-names>J</given-names></name><name><surname>Hay</surname><given-names>J</given-names></name><name><surname>Veldhuizen</surname><given-names>S</given-names></name><name><surname>Faught</surname><given-names>B</given-names></name></person-group><article-title>Comparison of VO2 maximum obtained from 20 m shuttle run and cycle ergometer in children with and without developmental coordination disorder</article-title><source>Res Dev Disabil</source><year>2010</year><volume>31</volume><fpage>1332</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20702060</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longhurst</surname><given-names>JC</given-names></name><name><surname>Stebbins</surname><given-names>CL</given-names></name></person-group><article-title>The power athlete</article-title><source>Cardiol Clin</source><year>1997</year><volume>15</volume><fpage>413</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">9276166</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderssen</surname><given-names>SA</given-names></name><name><surname>Cooper</surname><given-names>AR</given-names></name><name><surname>Riddoch</surname><given-names>C</given-names></name><name><surname>Sardinha</surname><given-names>LB</given-names></name><name><surname>Harro</surname><given-names>M</given-names></name><name><surname>Brage</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Low cardiorespiratory fitness is a strong predictor for clustering of cardiovascular disease risk factors in children independent of country, age and sex</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2007</year><volume>14</volume><fpage>526</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">17667643</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>GL</given-names></name><name><surname>Killian</surname><given-names>KJ</given-names></name><name><surname>Summers</surname><given-names>E</given-names></name><name><surname>Jones</surname><given-names>NL</given-names></name></person-group><article-title>Inspiratory muscle forces and endurance in maximum resistive loading</article-title><source>J Appl Physiol</source><year>1985</year><volume>58</volume><fpage>1608</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">3997725</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamunér</surname><given-names>AR</given-names></name><name><surname>Moreno</surname><given-names>MA</given-names></name><name><surname>Camargo</surname><given-names>TM</given-names></name><name><surname>Graetz</surname><given-names>JP</given-names></name><name><surname>Rebelo</surname><given-names>AC</given-names></name><name><surname>Tamburús</surname><given-names>NY</given-names></name><etal></etal></person-group><article-title>Assessment of subjective perceived exertion at the anaerobic threshold with the borg CR-10 Scale</article-title><source>J Sports Sci Med</source><year>2011</year><volume>10</volume><fpage>130</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">24149305</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandhu</surname><given-names>JS</given-names></name><name><surname>Shah</surname><given-names>B</given-names></name><name><surname>Shenoy</surname><given-names>S</given-names></name><name><surname>Chauhan</surname><given-names>S</given-names></name><name><surname>Lavekar</surname><given-names>GS</given-names></name><name><surname>Padhi</surname><given-names>MM</given-names></name></person-group><article-title>Effects of <italic>Withania somnifera</italic> (<italic>Ashwagandha</italic>) and <italic>Terminalia arjuna</italic> (<italic>Arjuna</italic>) on physical performance and cardiorespiratory endurance in healthy young adults</article-title><source>Int J Ayurveda Res</source><year>2010</year><volume>1</volume><fpage>144</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21170205</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leger</surname><given-names>LA</given-names></name><name><surname>Lambert</surname><given-names>J</given-names></name></person-group><article-title>A maximal multistage 20m shuttle run test to predict VO2 max</article-title><source>Eur J Appl Physiol</source><year>1982</year><volume>49</volume><fpage>1</fpage><lpage>12</lpage></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>NY</given-names></name><name><surname>Plowman</surname><given-names>SA</given-names></name><name><surname>Looney</surname><given-names>MA</given-names></name></person-group><article-title>The reliability and validity of the 20-meter shuttle test in American students 12 to 15 years old</article-title><source>Res Q Exerc Sport</source><year>1992</year><volume>63</volume><fpage>360</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">1439160</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raut</surname><given-names>AA</given-names></name><name><surname>Rege</surname><given-names>NN</given-names></name><name><surname>Tadvi</surname><given-names>FM</given-names></name><name><surname>Solanki</surname><given-names>PV</given-names></name><name><surname>Kene</surname><given-names>KR</given-names></name><name><surname>Shirolkar</surname><given-names>SG</given-names></name><etal></etal></person-group><article-title>Exploratory study to evaluate tolerability, safety, and activity of <italic>Ashwagandha</italic> (<italic>Withania somnifera</italic>) in healthy volunteers</article-title><source>J Ayurveda Integr Med</source><year>2012</year><volume>3</volume><fpage>111</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">23125505</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Begum</surname><given-names>VH</given-names></name><name><surname>Sadique</surname><given-names>J</given-names></name></person-group><article-title>Effect of <italic>Withania somnifera</italic> on glycosaminoglycan synthesis in carrageenin-induced air pouch granuloma</article-title><source>Biochem Med Metab Biol</source><year>1987</year><volume>38</volume><fpage>272</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">2963652</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziauddin</surname><given-names>M</given-names></name><name><surname>Phansalkar</surname><given-names>N</given-names></name><name><surname>Patki</surname><given-names>P</given-names></name><name><surname>Diwanay</surname><given-names>S</given-names></name><name><surname>Patwardhan</surname><given-names>B</given-names></name></person-group><article-title>Studies on the immunomodulatory effects of <italic>Ashwagandha</italic></article-title><source>J Ethnopharmacol</source><year>1996</year><volume>50</volume><fpage>69</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">8866726</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>McArdle</surname><given-names>WD</given-names></name><name><surname>Katch</surname><given-names>FI</given-names></name><name><surname>Katch</surname><given-names>VL</given-names></name></person-group><source>Exercise Physiology: Energy, Nutrition and Human Performance</source><year>1996</year><edition>4th ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Lea and Febiger</publisher-name></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>KJ</given-names></name><name><surname>Quintanilha</surname><given-names>AT</given-names></name><name><surname>Brooks</surname><given-names>GA</given-names></name><name><surname>Packer</surname><given-names>L</given-names></name></person-group><article-title>Free radicals and tissue damage produced by exercise</article-title><source>Biochem Biophys Res Commun</source><year>1982</year><volume>31</volume><issue>107</issue><fpage>1198</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">6291524</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>SK</given-names></name><name><surname>Mohanty</surname><given-names>I</given-names></name><name><surname>Talwar</surname><given-names>KK</given-names></name><name><surname>Dinda</surname><given-names>A</given-names></name><name><surname>Joshi</surname><given-names>S</given-names></name><name><surname>Bansal</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>Cardioprotection from ischemia and reperfusion injury by <italic>Withania somnifera</italic>: a hemodynamic, biochemical and histopathological assessment</article-title><source>Mol Cell Biochem</source><year>2004</year><volume>260</volume><fpage>39</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">15228084</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohanty</surname><given-names>I</given-names></name><name><surname>Arya</surname><given-names>DS</given-names></name><name><surname>Dinda</surname><given-names>A</given-names></name><name><surname>Talwar</surname><given-names>KK</given-names></name><name><surname>Joshi</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>SK</given-names></name></person-group><article-title>Mechanisms of cardioprotective effect of <italic>Withania somnifera</italic> in experimentally induced myocardial infarction</article-title><source>Basic Clin Pharmacol Toxicol</source><year>2004</year><volume>94</volume><fpage>184</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">15078343</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="book"><article-title>WHO-QOL-BREF Introduction. Administration, Scoring and Generic Version of the Assessment: Field Trial Version; December, 1996.WHO/MSA/MNH/PSF/97</article-title><year>1996</year><date-in-citation>Last retrieved on 2013 Sep 06</date-in-citation><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><comment>from <uri xlink:type="simple" xlink:href="http://www.who.int/mental_health/media/68.pdf">http://www.who.int/mental_health/media/68.pdf</uri></comment></element-citation></ref></ref-list></back></article>